|
1
|
King AR, Lodola A, Carmi C, Fu J, Mor M
and Piomelli D: A critical cysteine residue in monoacylglycerol
lipase is targeted by a new class of isothiazolinone-based enzyme
inhibitors. Br J Pharmacol. 157:974–983. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blankman JL, Simon GM and Cravatt BF: A
comprehensive profile of brain enzymes that hydrolyze the
endocannabinoid 2-arachidonoylglycerol. Chem Biol. 14:1347–1356.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pisanti S, Picardi P, D'Alessandro A,
Laezza C and Bifulco M: The endocannabinoid signaling system in
cancer. Trends Pharmacol Sci. 34:273–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hermanson DJ and Marnett LJ: Cannabinoids,
endocannabinoids, and cancer. Cancer Metastasis Rev. 30:599–612.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Panikashvili D, Simeonidou C, Ben-Shabat
S, Hanus L, Breuer A, Mechoulam R and Shohami E: An endogenous
cannabinoid (2-AG) is neuroprotective after brain injury. Nature.
413:527–531. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Long JZ, Li W, Booker L, Burston JJ,
Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, Selley DE, Parsons
LH, et al: Selective blockade of 2-arachidonoylglycerol hydrolysis
produces cannabinoid behavioral effects. Nat Chem Biol. 5:37–44.
2009. View Article : Google Scholar :
|
|
7
|
Nomura DK, Long JZ, Niessen S, Hoover HS,
Ng SW and Cravatt BF: Monoacylglycerol lipase regulates a fatty
acid network that promotes cancer pathogenesis. Cell. 140:49–61.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nomura DK, Lombardi DP, Chang JW, Niessen
S, Ward AM, Long JZ, Hoover HH and Cravatt BF: Monoacylglycerol
lipase exerts dual control over endocannabinoid and fatty acid
pathways to support prostate cancer. Chem Biol. 18:846–856. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zlobec I and Lugli A: Epithelial
mesenchymal transition and tumor budding in aggressive colorectal
cancer: Tumor budding as oncotarget. Oncotarget. 1:651–661. 2010.
View Article : Google Scholar
|
|
10
|
Joyce T, Cantarella D, Isella C, Medico E
and Pintzas A: A molecular signature for epithelial to mesenchymal
transition in a human colon cancer cell system is revealed by
large-scale microarray analysis. Clin Exp Metastasis. 26:569–587.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye L, Zhang B, Seviour EG, Tao KX, Liu XH,
Ling Y, Chen JY and Wang GB: Monoacylglycerol lipase (MAGL)
knockdown inhibits tumor cells growth in colorectal cancer. Cancer
Lett. 307:6–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hector S and Prehn JH: Apoptosis signaling
proteins as prognostic biomarkers in colorectal cancer: A review.
Biochim Biophys Acta. 1795:117–129. 2009.PubMed/NCBI
|
|
13
|
Prabhudesai SG, Rekhraj S, Roberts G,
Darzi AW and Ziprin P: Apoptosis and chemo-resistance in colorectal
cancer. J Surg Oncol. 96:77–88. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O'Leary DP, Bhatt L, Woolley JF, Gough DR,
Wang JH, Cotter TG and Redmond HP: TLR-4 signalling accelerates
colon cancer cell adhesion via NF-κB mediated transcriptional
up-regulation of Nox-1. PLoS One. 7:e441762012. View Article : Google Scholar
|
|
16
|
Bai J, Chen J, Ma M, Cai M, Xu F, Wang G,
Tao K and Shuai X: Inhibiting enhancer of zeste homolog 2 promotes
cellular senescence in gastric cancer cells SGC-7901 by activation
of p21 and p16. DNA Cell Biol. 33:337–344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen
J, Xi H, Li J and Zheng H: Krüppel-like factor 4 acts as an
oncogene in colon cancer stem cell-enriched spheroid cells. PLoS
One. 8:e560822013. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Croker BA, O'Donnell JA, Nowell CJ,
Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang
JG, et al: Fas-mediated neutrophil apoptosis is accelerated by Bid,
Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc Natl Acad Sci
USA. 108:13135–13140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JG, McKinney KQ, Pavlopoulos AJ, Park
JH and Hwang S: Identification of anti-metastatic drug and natural
compound targets in isogenic colorectal cancer cells. J Proteomics.
113:326–336. 2015. View Article : Google Scholar
|
|
21
|
Schlosburg JE, Blankman JL, Long JZ,
Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston
JJ, et al: Chronic monoacylglycerol lipase blockade causes
functional antagonism of the endocannabinoid system. Nat Neurosci.
13:1113–1119. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gustafsson SB, Palmqvist R, Henriksson ML,
Dahlin AM, Edin S, Jacobsson SO, Öberg Å and Fowler CJ: High tumour
cannabinoid CB1 receptor immunoreactivity negatively impacts
disease-specific survival in stage II microsatellite stable
colorectal cancer. PLoS One. 6:e230032011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guzmán M: Cannabinoids: Potential
anticancer agents. Nat Rev Cancer. 3:745–755. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeestraten EC, Benard A, Reimers MS,
Schouten PC, Liefers GJ, van de Velde CJ and Kuppen PJ: The
prognostic value of the apoptosis pathway in colorectal cancer: A
review of the literature on biomarkers identified by
immunohistochemistry. Biomark Cancer. 5:13–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moreno A, Figueras A, Lloveras B, Escobedo
A, Griera E, Sierra A and Fabra A: Apoptosis in ductal carcinoma in
situ of the breast. Breast J. 7:245–248. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi BH, Kim W, Wang QC, Kim DC, Tan SN,
Yong JW, Kim KT and Yoon HS: Kinetin riboside preferentially
induces apoptosis by modulating Bcl-2 family proteins and caspase-3
in cancer cells. Cancer Lett. 261:37–45. 2008. View Article : Google Scholar
|
|
27
|
Zhao S, Konopleva M, Cabreira-Hansen M,
Xie Z, Hu W, Milella M, Estrov Z, Mills GB and Andreeff M:
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD
and promotes apoptosis in myeloid leukemias. Leukemia. 18:267–275.
2004. View Article : Google Scholar
|
|
28
|
Kalluri R and Weinberg RA: The basics of
epithelialmesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Joyce T, Cantarella D, Isella C, Medico E
and Pintzas A: A molecular signature for Epithelial to Mesenchymal
transition in a human colon cancer cell system is revealed by
large-scale microarray analysis. Clin Exp Metastasis. 26:569–587.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu WR, Lian YF, Peng LX, Lei JJ, Deng CC,
Xu M, Feng QS, Chen LZ, Bei JX and Zeng YX: Monoacylglycerol lipase
promotes metastases in nasopharyngeal carcinoma. Int J Clin Exp
Pathol. 7:3704–3713. 2014.PubMed/NCBI
|
|
32
|
Neil JR, Johnson KM, Nemenoff RA and
Schiemann WP: Cox-2 inactivates Smad signaling and enhances EMT
stimulated by TGF-beta through a PGE2-dependent mechanism.
Carcinogenesis. 29:2227–2235. 2008. View Article : Google Scholar : PubMed/NCBI
|
